Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$63.83 - $80.0 $187,660 - $235,200
-2,940 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$76.85 - $89.45 $225,938 - $262,983
2,940 New
2,940 $228,000
Q3 2021

Oct 26, 2021

SELL
$73.77 - $83.61 $9.8 Million - $11.1 Million
-132,858 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$80.5 - $88.01 $3.45 Million - $3.77 Million
-42,843 Reduced 24.38%
132,858 $10.7 Million
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $225,091 - $253,530
-2,947 Reduced 1.65%
175,701 $14.8 Million
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $89,035 - $97,267
1,181 Added 0.67%
178,648 $14.3 Million
Q3 2020

Nov 13, 2020

SELL
$78.33 - $90.73 $62,507 - $72,402
-798 Reduced 0.45%
177,467 $14.3 Million
Q2 2020

Aug 18, 2020

SELL
$78.66 - $94.14 $270,669 - $323,935
-3,441 Reduced 1.89%
178,265 $15.3 Million
Q1 2020

May 21, 2020

SELL
$71.57 - $93.3 $854,402 - $1.11 Million
-11,938 Reduced 6.16%
181,706 $14.8 Million
Q4 2019

Feb 18, 2020

BUY
$76.7 - $88.45 $2.19 Million - $2.53 Million
28,617 Added 17.34%
193,644 $16.2 Million
Q3 2019

Nov 19, 2019

BUY
$81.4 - $89.78 $300,447 - $331,377
3,691 Added 2.29%
165,027 $14.4 Million
Q2 2019

Aug 16, 2019

BUY
$73.44 - $82.41 $1.98 Million - $2.22 Million
26,920 Added 20.03%
161,336 $13.2 Million
Q1 2019

May 15, 2019

BUY
$64.48 - $81.31 $2.17 Million - $2.74 Million
33,659 Added 33.41%
134,416 $10.9 Million
Q4 2018

Feb 22, 2019

BUY
$61.45 - $77.8 $5.76 Million - $7.29 Million
93,674 Added 1322.52%
100,757 $6.63 Million
Q3 2018

Nov 15, 2018

SELL
$70.71 - $77.75 $84,003 - $92,367
-1,188 Reduced 14.36%
7,083 $546,000
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $524,629 - $623,716
8,271 New
8,271 $610,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.